首页>
外国专利>
CD24HICD38HI TRANSITIONAL B CELLS AND CD9 AS NEW BIOMARKER OF LONG-TERM HUMAN LUNG ALLOGRAFT SURVIVAL
CD24HICD38HI TRANSITIONAL B CELLS AND CD9 AS NEW BIOMARKER OF LONG-TERM HUMAN LUNG ALLOGRAFT SURVIVAL
展开▼
机译:CD24HICD38HI过渡性B细胞和CD9作为长期人肺异体移植存活的新生物标记
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an in vitro method for determining the risk of occurrence of chronic lung graft dysfunction in a human subject comprising: a) measuring the level of CD9 + B cells in a blood sample of the subject, b) comparing the level of CD9 + B cells measured at step a) with one or more reference values of the level of CD9 + B cells, and c) determining the risk of occurrence of chronic lung graft dysfunction in the said subject from the comparison performed at step b).
展开▼